secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001193125-25-326821
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio director Mark Iwicki withdraws resignation, remains Board Chair and committee member
--------------------------------------------------------------------------------

- Mark Iwicki had previously notified intention to resign from Board effective Dec 31, 2025 to focus on CEO role at Inhibikase Therapeutics.
- On Dec 17, 2025, Iwicki withdrew resignation with full Board support, effective immediately, citing reduced board commitments.
- He will continue as Chair of the Board and Compensation Committee, and as a member of the Audit Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312525326821/0001193125-25-326821-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312525326821/d29360d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-326821

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer